Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 7SANOFI-AVENTIS CANADA INC
02 9BAYER INC
03 4NOVO NORDISK CANADA INC
04 7TAKEDA CANADA INC
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : KIT
Dosage Strength : 250UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430290
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : KIT
Dosage Strength : 500UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430304
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : KIT
Dosage Strength : 750UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430312
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : KIT
Dosage Strength : 1000UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430320
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1500UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430339
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 2000UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430347
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN
Brand Name : ELOCTATE
Dosage Form : KIT
Dosage Strength : 3000UNIT/VIAL
Packaging : 3ML
Approval Date :
Application Number : 2430355
Regulatory Info : Schedule D
Registration Country : Canada
